LAVA Therapeutics's total assets for Q3 2024 were $83.36M, a decrease of -9.67% from the previous quarter. LVTX total liabilities were $50.36M for the fiscal quarter, a 1.94% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.